Status:
COMPLETED
Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone
Lead Sponsor:
Bayer
Conditions:
Hyperphosphatemia
Dialysis
Eligibility:
All Genders
20+ years
Phase:
PHASE2
Brief Summary
To measure lanthanum concentrations in bone in patients with hyperphosphatemia receiving dialysis
Eligibility Criteria
Inclusion
- Patients undergoing dialysis or plan to start dialysis before the initial administration of the study medication
Exclusion
- Patients with severe hypocalcemia (adjusted serum calcium level of \<7.5 mg/dL)
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00767637
Start Date
June 1 2005
End Date
October 1 2008
Last Update
June 20 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Isesaki, Gunma, Japan, 379-2211
2
Yonago, Tottori, Japan, 683-0002